{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:28:00Z","timestamp":1793827680485,"version":"4.6.1"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":50,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Health Research Program of Anhui","award":["AHWJ2023A30169"],"award-info":[{"award-number":["AHWJ2023A30169"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03218-9","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:54:48Z","timestamp":1780293288000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Estimated glucose disposal rate outperforms thirteen other insulin resistance indices in predicting new-onset cardiometabolic multimorbidity: a longitudinal study from the china health and retirement longitudinal study (CHARLS) and cross-sectional replication from the national health and nutrition examination survey (NHANES)"],"prefix":"10.1186","volume":"25","author":[{"given":"Enfa","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruimeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingtian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"1","key":"3218_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1001\/jama.2015.7008","volume":"314","author":"E Di Angelantonio","year":"2015","unstructured":"Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, et al. Association of Cardiometabolic Multimorbidity With Mortality. JAMA. 2015;314(1):52\u201360.","journal-title":"JAMA"},{"issue":"34","key":"3218_CR2","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1093\/eurheartj\/ehab413","volume":"42","author":"Y Han","year":"2021","unstructured":"Han Y, Hu Y, Yu C, Guo Y, Pei P, Yang L, et al. Lifestyle, cardiometabolic disease, and multimorbidity in a prospective Chinese study. Eur Heart J. 2021;42(34):3374\u201384.","journal-title":"Eur Heart J"},{"issue":"3","key":"3218_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-024476","volume":"9","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang X, Shen P, Si Y, Liu X, Xu Z, et al. Multimorbidity of cardiometabolic diseases: prevalence and risk for mortality from one million Chinese adults in a longitudinal cohort study. BMJ Open. 2019;9(3):e024476.","journal-title":"BMJ Open"},{"issue":"6","key":"3218_CR4","doi-asserted-by":"publisher","first-page":"e265","DOI":"10.1016\/S2666-7568(23)00054-5","volume":"4","author":"Y Jin","year":"2023","unstructured":"Jin Y, Liang J, Hong C, Liang R, Luo Y. Cardiometabolic multimorbidity, lifestyle behaviours, and cognitive function: a multicohort study. Lancet Healthy Longev. 2023;4(6):e265\u201373.","journal-title":"Lancet Healthy Longev"},{"issue":"1","key":"3218_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-022-00376-4","volume":"8","author":"ST Skou","year":"2022","unstructured":"Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, et al. Multimorbidity. Nat Rev Dis Primers. 2022;8(1):48.","journal-title":"Nat Rev Dis Primers"},{"issue":"9836","key":"3218_CR6","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/S0140-6736(12)60240-2","volume":"380","author":"K Barnett","year":"2012","unstructured":"Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet (London, England). 2012;380(9836):37\u201343.","journal-title":"Lancet (London, England)"},{"key":"3218_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154766","volume":"119","author":"MA Hill","year":"2021","unstructured":"Hill MA, Yang Y, Zhang L, Sun Z, Jia G, Parrish AR, et al. Insulin resistance, cardiovascular stiffening and cardiovascular disease. Metabolism. 2021;119:154766.","journal-title":"Metabolism"},{"issue":"1","key":"3218_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12933-018-0762-4","volume":"17","author":"V Ormazabal","year":"2018","unstructured":"Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, Zu\u00f1iga FA. Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol. 2018;17(1):122.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR9","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12933-022-01511-x","volume":"21","author":"LC Tao","year":"2022","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR10","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1186\/s12933-025-02972-6","volume":"24","author":"C Wang","year":"2025","unstructured":"Wang C, He S, Xie G, Zhang S, Xiong Z, Lu H, et al. Associations of longitudinal trajectories of triglyceride-glucose index combined with classical and novel obesity indices and cardiovascular disease: evidence from a nationwide prospective cohort study in China. Cardiovasc Diabetol. 2025;24(1):431.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12933-025-03038-3","volume":"25","author":"X Chen","year":"2025","unstructured":"Chen X, Zhao X, Fei H, Zhang Y, Pang J, Liu Z, et al. Combined association of triglyceride-glucose index and the atherogenic index of plasma with the incidence of cardiovascular diseases among middle-aged and older population. Cardiovasc Diabetol. 2025;25(1):19.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12933-025-02761-1","volume":"24","author":"L Zhou","year":"2025","unstructured":"Zhou L, Wang J, Zhou Z, Wang L, Guo Q, Zeng H, et al. Long-term dual-trajectories of TyG and LAP and their association with cardiometabolic multimorbidity in midlife: the CARDIA study. Cardiovasc Diabetol. 2025;24(1):198.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR13","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13098-026-02089-0","volume":"18","author":"C Zhao","year":"2026","unstructured":"Zhao C, Li H, Jiang X, Yang Y, Yang Y, Zhang H, et al. Insulin-resistance indices and cardiovascular mortality in cardiovascular-kidney-metabolic syndrome stage 2: a comparative analysis of eGDR, TyG and METS-IR. Diabetol Metab Syndr. 2026;18(1):54.","journal-title":"Diabetol Metab Syndr"},{"key":"3218_CR14","doi-asserted-by":"crossref","unstructured":"Ni G, Chen Z, Zhu A, Cheang I, Zhu X, Fu Y, Zhang H, Li X: Association between C-reactive protein-triglyceride glucose index (CTI) and cardiovascular and all-cause mortality risk among the elderly population: insights from three datasets. Clinical research in cardiology : official journal of the German Cardiac Society 2026.","DOI":"10.1007\/s00392-025-02830-1"},{"key":"3218_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2025.120591","volume":"412","author":"X Yao","year":"2026","unstructured":"Yao X, Liu L, Zhao L, Zhang N. Association between the single-point insulin sensitivity estimator and cardiovascular disease incidence: a prospective nationwide cohort study involving two cohorts. Atherosclerosis. 2026;412:120591.","journal-title":"Atherosclerosis"},{"issue":"1","key":"3218_CR16","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12944-025-02742-z","volume":"24","author":"E Zhao","year":"2025","unstructured":"Zhao E, Wang R, Chen Y, Xie H, Gao Y, Dong B, et al. Evaluation of a new TyG indicator, TyHGB, in predicting non-alcoholic fatty liver disease: evidence from two independent populations. Lipids Health Dis. 2025;24(1):342.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3218_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.3764","volume":"40","author":"D Xiao","year":"2024","unstructured":"Xiao D, Sun H, Chen L, Li X, Huo H, Zhou G, et al. Assessment of six surrogate insulin resistance indexes for predicting cardiometabolic multimorbidity incidence in Chinese middle-aged and older populations: insights from the China Health and Retirement Longitudinal Study. Diabetes Metab Res Rev. 2024;40(1):e3764.","journal-title":"Diabetes Metab Res Rev"},{"issue":"1","key":"3218_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-023-01205-8","volume":"15","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Zhao L, Lu Y, Meng X, Zhou X. Relationship of triglyceride-glucose index with cardiometabolic multi-morbidity in China: evidence from a national survey. Diabetol Metab Syndr. 2023;15(1):226.","journal-title":"Diabetol Metab Syndr"},{"key":"3218_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2024.111894","volume":"217","author":"Q Xu","year":"2024","unstructured":"Xu Q, Tian X, Xia X, Zhang Y, Zheng M, Wang A. Estimated glucose disposal rate, high sensitivity C-reactive protein and cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide prospective cohort study. Diabetes Res Clin Pract. 2024;217:111894.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1","key":"3218_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02256-5","volume":"23","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Zhao L, Lu Y, Xiao Y, Zhou X. Insulin resistance assessed by estimated glucose disposal rate and risk of incident cardiovascular diseases among individuals without diabetes: findings from a nationwide, population based, prospective cohort study. Cardiovasc Diabetol. 2024;23(1):194.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02699-z","volume":"24","author":"W Cheng","year":"2025","unstructured":"Cheng W, Feng X, Kang P, Liu J, Tang B. Estimated glucose disposal rate and the dynamic transitions of cardiometabolic multimorbidity and all-cause mortality in prediabetes: a multistate trajectory analysis. Lipids Health Dis. 2025;24(1):317.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3218_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK Biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR23","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/ije\/dys203","volume":"43","author":"Y Zhao","year":"2014","unstructured":"Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61\u20138.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"3218_CR24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1186\/s12933-025-02939-7","volume":"24","author":"X Ruan","year":"2025","unstructured":"Ruan X, Ling Y, Chen J, Xiang Y, Ruan H, Zhang W, et al. Joint effects of triglyceride glucose index and its obesity-related derivatives with estimated glucose disposal rate on cardiometabolic multimorbidity in middle-aged and older Chinese adults: a nationwide cohort study. Cardiovasc Diabetol. 2025;24(1):382.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12933-026-03077-4","volume":"25","author":"T Jin","year":"2026","unstructured":"Jin T, Tang X, Han Y, Fan H, Qin Q, Jiang H, et al. Relationship between nine triglyceride-glucose-related indices and cardiometabolic multimorbidity incidence in patients with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2026;25(1):36.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"3218_CR26","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.2337\/dci23-0036","volume":"46","author":"DB Sacks","year":"2023","unstructured":"Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Lernmark \u00c5, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of Diabetes Mellitus. Diabetes Care. 2023;46(10):e151\u201399.","journal-title":"Diabetes Care"},{"issue":"1","key":"3218_CR27","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.114.04012","volume":"65","author":"SS Yoon","year":"2015","unstructured":"Yoon SS, Gu Q, Nwankwo T, Wright JD, Hong Y, Burt V. Trends in blood pressure among adults with hypertension: United States, 2003 to 2012. Hypertension. 2015;65(1):54\u201361.","journal-title":"Hypertension"},{"issue":"19","key":"3218_CR28","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, Tighiouart H, Wang D, Sang Y, et al. New creatinine- and Cystatin C-Based equations to estimate GFR without race. N Engl J Med. 2021;385(19):1737\u201349.","journal-title":"N Engl J Med"},{"issue":"4","key":"3218_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/dju041","volume":"106","author":"MS Pepe","year":"2014","unstructured":"Pepe MS, Janes H, Li CI. Net risk reclassification p values: valid or misleading? J Natl Cancer Inst. 2014;106(4):dju041.","journal-title":"J Natl Cancer Inst"},{"issue":"19","key":"3218_CR30","doi-asserted-by":"publisher","first-page":"3405","DOI":"10.1002\/sim.5804","volume":"33","author":"J Hilden","year":"2014","unstructured":"Hilden J, Gerds TA. A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index. Stat Med. 2014;33(19):3405\u201314.","journal-title":"Stat Med"},{"key":"3218_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2015.00231","volume":"6","author":"G Jia","year":"2015","unstructured":"Jia G, Aroor AR, DeMarco VG, Martinez-Lemus LA, Meininger GA, Sowers JR. Vascular stiffness in insulin resistance and obesity. Front Physiol. 2015;6:231.","journal-title":"Front Physiol"},{"issue":"14","key":"3218_CR32","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1113\/JP276747","volume":"598","author":"M Nakamura","year":"2020","unstructured":"Nakamura M, Sadoshima J. Cardiomyopathy in obesity, insulin resistance and diabetes. J Physiol. 2020;598(14):2977\u201393.","journal-title":"J Physiol"},{"issue":"1","key":"3218_CR33","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12933-025-03066-z","volume":"25","author":"Z Tian","year":"2026","unstructured":"Tian Z, Xue F, Chen A, Huang Y, Su X. Triglyceride-glucose-related indices and cardiovascular outcomes in individuals with pre-frailty or frailty: insights from a prospective cohort analysis using UK Biobank data. Cardiovasc Diabetol. 2026;25(1):50.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3218_CR34","doi-asserted-by":"publisher","first-page":"626","DOI":"10.2337\/diabetes.49.4.626","volume":"49","author":"KV Williams","year":"2000","unstructured":"Williams KV, Erbey JR, Becker D, Arslanian S, Orchard TJ. Can clinical factors estimate insulin resistance in type 1 diabetes? Diabetes. 2000;49(4):626\u201332.","journal-title":"Diabetes"},{"issue":"8","key":"3218_CR35","doi-asserted-by":"publisher","first-page":"2280","DOI":"10.2337\/dc12-1693","volume":"36","author":"EJ Epstein","year":"2013","unstructured":"Epstein EJ, Osman JL, Cohen HW, Rajpathak SN, Lewis O, Crandall JP. Use of the estimated glucose disposal rate as a measure of insulin resistance in an urban multiethnic population with type 1 diabetes. Diabetes Care. 2013;36(8):2280\u20135.","journal-title":"Diabetes Care"},{"issue":"1","key":"3218_CR36","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12933-023-01925-1","volume":"22","author":"Z Lu","year":"2023","unstructured":"Lu Z, Xiong Y, Feng X, Yang K, Gu H, Zhao X, et al. Insulin resistance estimated by estimated glucose disposal rate predicts outcomes in acute ischemic stroke patients. Cardiovasc Diabetol. 2023;22(1):225.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3218_CR37","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/dom.16132","volume":"27","author":"H Huang","year":"2025","unstructured":"Huang H, Xiong Y, Zhou J, Tang Y, Chen F, Li G, et al. The predictive value of estimated glucose disposal rate and its association with myocardial infarction, heart failure, atrial fibrillation and ischemic stroke. Diabetes Obes Metab. 2025;27(3):1359\u201368.","journal-title":"Diabetes Obes Metab"},{"issue":"21","key":"3218_CR38","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","volume":"143","author":"TM Powell-Wiley","year":"2021","unstructured":"Powell-Wiley TM, Poirier P, Burke LE, Despr\u00e9s JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2021;143(21):e984\u20131010.","journal-title":"Circulation"},{"key":"3218_CR39","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.puhe.2023.12.010","volume":"227","author":"S Wang","year":"2024","unstructured":"Wang S, Shi S, Huang Y, Huang H, Zhong VW. Severity of abdominal obesity and cardiometabolic diseases in US adults. Public Health. 2024;227:154\u201362.","journal-title":"Public Health"},{"key":"3218_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.00022","volume":"7","author":"A Chait","year":"2020","unstructured":"Chait A, den Hartigh LJ. Adipose tissue distribution, inflammation and its metabolic consequences, including diabetes and cardiovascular disease. Front Cardiovasc Med. 2020;7:22.","journal-title":"Front Cardiovasc Med"},{"issue":"4","key":"3218_CR41","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1530\/eje.0.1420315","volume":"142","author":"U Scherrer","year":"2000","unstructured":"Scherrer U, Sartori C. Defective nitric oxide synthesis: a link between metabolic insulin resistance, sympathetic overactivity and cardiovascular morbidity. Eur J Endocrinol. 2000;142(4):315\u201323.","journal-title":"Eur J Endocrinol"},{"key":"3218_CR42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052404","author":"RS Pinto","year":"2022","unstructured":"Pinto RS, Minanni CA, de Ara\u00fajo Lira AL, Passarelli M. Advanced glycation end products: a sweet flavor that embitters cardiovascular disease. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23052404.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3218_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02115-9","volume":"23","author":"K Dang","year":"2024","unstructured":"Dang K, Wang X, Hu J, Zhang Y, Cheng L, Qi X, et al. The association between triglyceride-glucose index and its combination with obesity indicators and cardiovascular disease: NHANES 2003-2018. Cardiovasc Diabetol. 2024;23(1):8.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR44","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s12933-024-02336-6","volume":"23","author":"Q Ren","year":"2024","unstructured":"Ren Q, Huang Y, Liu Q, Chu T, Li G, Wu Z. Association between triglyceride glucose-waist height ratio index and cardiovascular disease in middle-aged and older Chinese individuals: a nationwide cohort study. Cardiovasc Diabetol. 2024;23(1):247.","journal-title":"Cardiovasc Diabetol"},{"issue":"7","key":"3218_CR45","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ Res. 2021;128(7):951\u201368.","journal-title":"Circ Res"},{"issue":"7","key":"3218_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-023-00847-5","volume":"20","author":"PL Valenzuela","year":"2023","unstructured":"Valenzuela PL, Carrera-Bastos P, Castillo-Garc\u00eda A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20(7):475\u201394.","journal-title":"Nat Rev Cardiol"},{"issue":"7121","key":"3218_CR47","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nature05487","volume":"444","author":"LF Van Gaal","year":"2006","unstructured":"Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature. 2006;444(7121):875\u201380.","journal-title":"Nature"},{"key":"3218_CR48","volume":"7","author":"SS Choe","year":"2016","unstructured":"Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB. Adipose tissue remodeling: its role in energy metabolism and metabolic disorders. Front Endocrinol Lausanne. 2016;7:30.","journal-title":"Front Endocrinol Lausanne"},{"issue":"5","key":"3218_CR49","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1172\/JCI81507","volume":"125","author":"U Smith","year":"2015","unstructured":"Smith U. Abdominal obesity: a marker of ectopic fat accumulation. J Clin Invest. 2015;125(5):1790\u20132.","journal-title":"J Clin Invest"},{"key":"3218_CR50","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1381949","volume":"15","author":"X Ye","year":"2024","unstructured":"Ye X, Zhang G, Han C, Wang P, Lu J, Zhang M. The association between Chinese visceral adiposity index and cardiometabolic multimorbidity among Chinese middle-aged and older adults: a national cohort study. Front Endocrinol Lausanne. 2024;15:1381949.","journal-title":"Front Endocrinol Lausanne"},{"issue":"1","key":"3218_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-05114-w","volume":"15","author":"F Zhu","year":"2025","unstructured":"Zhu F, Peng N, Shi L, Hu Y, Zhang Q, Zhang M. Triglyceride-glucose index combined with body roundness index predicts cardiovascular risk in middle-aged and elderly individuals: a 10-year cohort study. Sci Rep. 2025;15(1):22062.","journal-title":"Sci Rep"},{"issue":"1","key":"3218_CR52","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12933-025-02854-x","volume":"24","author":"Y Yue","year":"2025","unstructured":"Yue Y, Li P, Sun Z, Murayama R, Li Z, Hashimoto K, et al. Association of novel triglyceride-glucose-related indices with incident stroke in early-stage cardiovascular-kidney-metabolic syndrome. Cardiovasc Diabetol. 2025;24(1):301.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/s12933-025-02604-z","volume":"24","author":"HM He","year":"2025","unstructured":"He HM, Xie YY, Chen Q, Li YK, Li XX, Fu SJ, et al. The synergistic effect of the triglyceride-glucose index and a body shape index on cardiovascular mortality: the construction of a novel cardiovascular risk marker. Cardiovasc Diabetol. 2025;24(1):69.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR54","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12933-022-01546-0","volume":"21","author":"X Liu","year":"2022","unstructured":"Liu X, Tan Z, Huang Y, Zhao H, Liu M, Yu P, et al. Relationship between the triglyceride-glucose index and risk of cardiovascular diseases and mortality in the general population: a systematic review and meta-analysis. Cardiovasc Diabetol. 2022;21(1):124.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR55","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12944-025-02836-8","volume":"25","author":"F Zhang","year":"2025","unstructured":"Zhang F, Zhang B, Huang X, Wang Z, Wang J, Lan H, et al. Comparison of the TyG index, TyG-traditional obesity indices, and TyG-novel obesity indices: does increased complexity help in predicting cardiometabolic multimorbidity? Lipids Health Dis. 2025;25(1):33.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3218_CR56","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02390-0","volume":"23","author":"S Li","year":"2024","unstructured":"Li S, An L, Fu Z, Zhang W, Liu H. Association between triglyceride-glucose related indices and all-cause and cause-specific mortality in the general population: a cohort study. Cardiovasc Diabetol. 2024;23(1):286.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR57","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3218_CR58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","volume":"150","author":"R Clarke","year":"1999","unstructured":"Clarke R, Shipley M, Lewington S, Youngman L, Collins R, Marmot M, et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol. 1999;150(4):341\u201353.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"3218_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12933-022-01453-4","volume":"21","author":"Y Yan","year":"2022","unstructured":"Yan Y, Wang D, Sun Y, Ma Q, Wang K, Liao Y, et al. Triglyceride-glucose index trajectory and arterial stiffness: results from Hanzhong Adolescent Hypertension Cohort Study. Cardiovasc Diabetol. 2022;21(1):33.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3218_CR60","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-01847-y","volume":"22","author":"H Yu","year":"2023","unstructured":"Yu H, Tao L, Li YG, Yang L, Liu D, Wang Y, et al. Association between triglyceride-glucose index trajectories and carotid atherosclerosis progression. Cardiovasc Diabetol. 2023;22(1):130.","journal-title":"Cardiovasc Diabetol"},{"issue":"4","key":"3218_CR61","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1111\/dom.70519","volume":"28","author":"Y Pan","year":"2026","unstructured":"Pan Y, Bi J. Long-term weight maintenance and risk of cardiometabolic multimorbidity and its subtypes in middle-aged and older adults: a pooled landmark analysis in China and the UK. Diabetes Obes Metab. 2026;28(4):3245\u201353.","journal-title":"Diabetes Obes Metab"},{"key":"3218_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-026-03109-z","author":"Y Lin","year":"2026","unstructured":"Lin Y, Tao J, Wang H, Guan H, Liu X, Dong X, et al. The association of c-reactive protein-triglyceride-glucose index with cardiometabolic multimorbidity in middle-aged and older adults: evidence from two cohort studies. Cardiovasc Diabetol. 2026. https:\/\/doi.org\/10.1186\/s12933-026-03109-z.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"3218_CR63","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-17-0883","volume":"178","author":"OY Bello-Chavolla","year":"2018","unstructured":"Bello-Chavolla OY, Almeda-Valdes P, Gomez-Velasco D, Viveros-Ruiz T, Cruz-Bautista I, Romo-Romo A, et al. METS-IR, a novel score to evaluate insulin sensitivity, is predictive of visceral adiposity and incident type 2 diabetes. Eur J Endocrinol. 2018;178(5):533\u201344.","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"3218_CR64","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.1111\/dom.15600","volume":"26","author":"S Deng","year":"2024","unstructured":"Deng S, Hu X, Zhang X. Association of single-point insulin sensitivity estimator index (SPISE) with future cardiovascular outcomes in patients with type 2 diabetes. Diabetes Obes Metab. 2024;26(7):2820\u20139.","journal-title":"Diabetes Obes Metab"},{"issue":"6","key":"3218_CR65","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1093\/ije\/dys168","volume":"42","author":"A Steptoe","year":"2013","unstructured":"Steptoe A, Breeze E, Banks J, Nazroo J. Cohort profile: the English longitudinal study of ageing. Int J Epidemiol. 2013;42(6):1640\u20138.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"3218_CR66","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002571","volume":"15","author":"A Singh-Manoux","year":"2018","unstructured":"Singh-Manoux A, Fayosse A, Sabia S, Tabak A, Shipley M, Dugravot A, et al. Clinical, socioeconomic, and behavioural factors at age 50 years and risk of cardiometabolic multimorbidity and mortality: a cohort study. PLoS Med. 2018;15(5):e1002571.","journal-title":"PLoS Med"},{"issue":"1","key":"3218_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1474-7","volume":"18","author":"H Freisling","year":"2020","unstructured":"Freisling H, Viallon V, Lennon H, Bagnardi V, Ricci C, Butterworth AS, et al. Lifestyle factors and risk of multimorbidity of cancer and cardiometabolic diseases: a multinational cohort study. BMC Med. 2020;18(1):5.","journal-title":"BMC Med"},{"issue":"1","key":"3218_CR68","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-023-02114-w","volume":"23","author":"F Li","year":"2024","unstructured":"Li F, Wang Y, Shi B, Sun S, Wang S, Pang S, et al. Association between the cumulative average triglyceride glucose-body mass index and cardiovascular disease incidence among the middle-aged and older population: a prospective nationwide cohort study in China. Cardiovasc Diabetol. 2024;23(1):16.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03218-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03218-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03218-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T12:33:32Z","timestamp":1784637212000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03218-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3218"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03218-9","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"19 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study involving human participants was granted by the Peking University Ethics Review Committee. All participants provided written informed consent prior to enrollment (IRB No.: 00001052\u201311015).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"205"}}